PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Me6TREN targets beta-catenin signaling to stimulate intestinal stem cell regeneration after radiation.

Mixed / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32929341 ↗2020Reported benefit

Me6TREN targets beta-catenin signaling to stimulate intestinal stem cell regeneration after radiation.

MixedRadiationC57BL/6 primary; BALB/c confirmatory survival; Lgr5-EGFP-IRES-creERT2 for organoid and intestinal stem cell studiesn = Three or more mice per group for immunohistochemistry; n pe…Subcutaneous injection2.5 mg/kg identified as optimal; dose-response tested at 0,…First dose within 1 hour after radiation exposure (day 0), so a post-exposure m…

Model: Radiation-induced acute gastrointestinal syndrome: whole-body irradiation at 8 to 14 Gy using a cobalt-60 irradiator, and abdominal X-ray irradiation at 14 Gy; survival observed for 30 days. In vitro 6 Gy for organoids and 10 Gy for IEC-6 cells

Subcutaneous Me6TREN at 2.5 mg/kg on days 0, 3, 6, 9 and 12 improved survival after 8 Gy whole-body irradiation (40% versus 0% with PBS), extended median survival after 14 Gy from 5 to 10 days, and raised survival after 14 Gy abdominal irradiation to 80% versus 15%, with increased crypt and villus…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.